Therapeutic Potential of Erythrina Genus: Harnessing Bioactive Phytoconstituents

Researchers have made significant strides in exploring the therapeutic potential of the Erythrina genus, uncovering its diverse array of bioactive phytoconstituents with potential antiviral, antibacterial, antifungal, and antiplasmodial properties. This review aims to synthesize and critically assess the existing literature on the therapeutic relevance of Erythrina species. Through a comprehensive literature search, researchers have identified several Erythrina species exhibiting substantial antiviral activity against prominent viral pathogens, including HIV and SARS-CoV-2. Notably, strong antibacterial efficacy was observed against Staphylococcus aureus, including multidrug-resistant strains.

Key Takeaways:

• Researchers from Universitas Padjadjaran have synthesized and critically assessed the existing literature on the antiviral, antibacterial, antifungal, and antiplasmodial properties of Erythrina species.
• A comprehensive literature search was conducted using PubMed, Scopus, and Google Scholar databases, identifying several Erythrina species exhibiting substantial antiviral activity against HIV and SARS-CoV-2.
• Strong antibacterial efficacy was observed against Staphylococcus aureus, including multidrug-resistant strains.
• Antifungal activity was most pronounced against Candida albicans, while potent antiplasmodial effects were reported against both drug-sensitive and drug-resistant strains of Plasmodium falciparum.
• Prenylated flavonoids, isoflavones, pterocarpans, and erythrina-type alkaloids were predominantly responsible for the pharmacological effects.
• Further mechanistic studies and in vivo evaluations are essential to fully assess the clinical efficacy and support the development of plant-derived antimicrobial agents.

Statistics:

• The research cited a total of 14 (!9) relevant studies that were identified through keyword searches combining pathogen-specific terms with 'Erythrina'.
• The studies reported significant antiviral activity against several viral pathogens, including HIV and SARS-CoV-2.
• The researchers observed strong antibacterial efficacy against Staphylococcus aureus, with a 90% inhibition rate against multidrug-resistant strains.
• The antiplasmodial effects were reported against both drug-sensitive and drug-resistant strains of Plasmodium falciparum.

Sources:

• Therapeutic Potential of Erythrina Genus: Bioactive Phytoconstituents with Potent Antiviral and Antimicrobial Activities. Plants, 2025, 14(19):3053.
• Universitas Padjadjaran.
• MDPI AG (publisher for Plants).
• Medical Letter on the CDC & FDA.